UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions

Clinical Microbiology Reviews, 2012-10, Vol.25 (4), p.682-707

2012

Volltextzugriff (PDF)

KPC-Producing, Multidrug-Resistant Klebsiella pneumoniae Sequence Type 258 as a Typical Opportunistic Pathogen

Antimicrobial Agents and Chemotherapy, 2013-10, Vol.57 (10), p.5144-5146

2013

Volltextzugriff (PDF)

Treating infections caused by carbapenemase-producing Enterobacteriaceae

Clinical microbiology and infection, 2014-09, Vol.20 (9), p.862-872

2014

Volltextzugriff (PDF)

Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers

Clinical microbiology and infection, 2006-02, Vol.12 (2), p.186-189

2006

Volltextzugriff (PDF)

Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment

Clinical microbiology and infection, 2019-08, Vol.25 (8), p.951-957

2019

Volltextzugriff (PDF)

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

Clinical microbiology and infection, 2011-08, Vol.17 (8), p.1135-1141

2011

Volltextzugriff (PDF)

Streptococcus pyogenes emm Types and Clusters during a 7-Year Period (2007 to 2013) in Pharyngeal and Nonpharyngeal Pediatric Isolates

Journal of clinical microbiology, 2015-07, Vol.53 (7), p.2015-2021

2015

Volltextzugriff (PDF)

Malaria in Europe: emerging threat or minor nuisance?

Clinical microbiology and infection, 2016-06, Vol.22 (6), p.487-493

2016

Volltextzugriff (PDF)

Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey

Journal of antimicrobial chemotherapy, 2008-01, Vol.61 (1), p.59-63

2008

Volltextzugriff (PDF)

Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria

Clinical microbiology and infection, 2012-05, Vol.18 (5), p.439-448

2012

Volltextzugriff (PDF)

Management of KPC-producing Klebsiella pneumoniae infections

Clinical microbiology and infection, 2018-02, Vol.24 (2), p.133-144

2018

Volltextzugriff (PDF)

Serum Bactericidal Activity of Three Different Dosing Regimens of Colistin with Implications for Optimum Clinical Use

Journal of chemotherapy (Florence), 2010-06, Vol.22 (3), p.175-178

2010

Volltextzugriff (PDF)

Risk factors for previously unknown meticillin-resistant Staphylococcus aureus carriage on admission to 13 surgical wards in Europe

The Journal of hospital infection, 2013-02, Vol.83 (2), p.107-113

2013

Volltextzugriff (PDF)

Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control

Clinical microbiology and infection, 2010-02, Vol.16 (2), p.102-111

2010

Volltextzugriff (PDF)

Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study

Journal of antimicrobial chemotherapy, 2021-02, Vol.76 (3), p.775-783

2021

Volltextzugriff (PDF)

The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2

International journal of antimicrobial agents, 2010-08, Vol.36 (2), p.190-191

2010

Volltextzugriff (PDF)

Discrepancies and Interpretation Problems in Susceptibility Testing of VIM-1-Producing Klebsiella pneumoniae Isolates

Journal of Clinical Microbiology, 2005-01, Vol.43 (1), p.494-496

2005

Volltextzugriff (PDF)

Colonization of High-Risk Children with Carbapenemase-Producing Enterobacteriaceae in Greece

Infection control and hospital epidemiology, 2013-07, Vol.34 (7), p.757-759

2013

Volltextzugriff (PDF)

Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria

Clinical microbiology and infection, 2020-12, Vol.26 (12), p.1644-1650

2020

Volltextzugriff (PDF)

Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections

European journal of clinical microbiology & infectious diseases, 2005-04, Vol.24 (4), p.272-275

2005

Volltextzugriff (PDF)

Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility

Clinical microbiology and infection, 2019-06, Vol.25 (6), p.711-716

2019

Volltextzugriff (PDF)

Activity of imipenem against VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model

Clinical microbiology and infection, 2007-02, Vol.13 (2), p.202-205

2007

Volltextzugriff (PDF)

A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients

Clinical microbiology and infection, 2005-09, Vol.11 (9), p.736-743

2005

Volltextzugriff (PDF)

The 3-day rule for stool cultures: should all patients with haematological malignancies be excluded?

Clinical microbiology and infection, 2018-12, Vol.24 (12), p.1342.e1-1342.e3

2018

Volltextzugriff (PDF)

Tuberculosis after anti-TNF therapy: a continuous learning process

Scandinavian journal of rheumatology, 2012-10, Vol.41 (5), p.401-403

2012

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(114)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(107)
Life Sciences & Biomedicine
(104)
Humans
(98)
Infectious Diseases
(80)
Female
(62)
Male
(61)
Biological And Medical Sciences
(54)
Medical Sciences
(52)
Microbiology
(50)
Adult
(43)
Middle Aged
(36)
Pharmacology. Drug Treatments
(28)
Aged
(27)
Anti-Bacterial Agents - Pharmacology
(27)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(26)
Pharmacology & Pharmacy
(22)
Anti-Bacterial Agents - Therapeutic Use
(20)
Adolescent
(17)
Child
(15)
Greece - Epidemiology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions

KPC-Producing, Multidrug-Resistant Klebsiella pneumoniae Sequence Type 258 as a Typical Opportunistic Pathogen

Treating infections caused by carbapenemase-producing Enterobacteriaceae

Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers

Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

Streptococcus pyogenes emm Types and Clusters during a 7-Year Period (2007 to 2013) in Pharyngeal and Nonpharyngeal Pediatric Isolates

Malaria in Europe: emerging threat or minor nuisance?

Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey

Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria

Management of KPC-producing Klebsiella pneumoniae infections

Serum Bactericidal Activity of Three Different Dosing Regimens of Colistin with Implications for Optimum Clinical Use

Risk factors for previously unknown meticillin-resistant Staphylococcus aureus carriage on admission to 13 surgical wards in Europe

Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control

Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study

The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2

Discrepancies and Interpretation Problems in Susceptibility Testing of VIM-1-Producing Klebsiella pneumoniae Isolates

Colonization of High-Risk Children with Carbapenemase-Producing Enterobacteriaceae in Greece

Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria

Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections

Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility

Activity of imipenem against VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model

A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients

The 3-day rule for stool cultures: should all patients with haematological malignancies be excluded?

Tuberculosis after anti-TNF therapy: a continuous learning process

Suchergebnisse filtern